Soley (Seren) Bayraktar, MD

Soley (Seren) Bayraktar, MD, MBA

Oncology Ardmore, OK

Medical Oncologist and hematologist


Office Address

  • 1220 Hall Pl
    Ardmore, OK 73401
    Phone: (580) 223-7091
    Fax: (580) 223-7395

Soley (Seren) Bayraktar, MD, MBA

Oncology Ardmore, OK

Medical Oncologist and hematologist

Clinical Specialties & Interests

  • Oncology: General Oncology

Education & Medical Training

  • Hacettepe University Faculty of Medicine
  • Jackson Memorial Hospital - Jackson Health SystemJackson Memorial Hospital - Jackson Health System
  • Mount Sinai Medical Center of Florida
  • University of Massachusetts
  • University of Texas Health Science CenterUniversity of Texas Health Science Center
  • Wayne State University School of MedicineWayne State University School of Medicine

Certifications & Licensure

  • OK State Medical LicenseOK State Medical License2012 - 2016
  • TX State Medical LicenseTX State Medical License2010 - 2016
  • American Board of Internal MedicineInternal Medicine, 2008
  • American Board of Internal MedicineHematology, 2011
  • American Board of Internal MedicineMedical Oncology, 2011

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 CertificationEpicCare Ambulatory EMR, Epic Systems Corporation, 2012, 2013
  • Annual Meeting Merit AwardAmerican Society of Clinical Oncology (ASCO), 2011
  • Grant for AACR Molecular Biology in Clinical Oncology WorkshopNational Institutes of Health (NIH), 2009

Clinical Trials

Publications & Presentations

PubMed

Books/Book Chapters

  • Tomatoes, Lycopene and Human Health Chapter: The Role of Tomato Lycopene in the Treatment of Prostate Cancer 
    Heath E, Seren S, Sahin K, Kucuk O
    Editors: Vanket Rao.Caledonian Press, Barcelona, Spain
    2006
  •   
    Kittaneh M, Bayraktar S, Montero A, MD, Snoo F, Glück S
    Editors: .
  •   
    Kittaneh M, Bayraktar S, Montero A, MD, Snoo F, Glück S
    Editors: .

Abstracts/Posters

  • Efficacy of Neoadjuvant Therapy with Trastuzumab Concurrent with Anthracycline- and Non-anthracycline-based Regimens for HER2-Positive Breast Cancer Bayraktar S, Gonzalez-Angulo AM, Lei X, Buzdar AU, Valero V, Melhem-Bertrandt A, Kuerer HM, Hortobagyi GN, Sahin AA, Meric-Bernstam F, 47th ASCO Annual Meeting, J Clin Oncol, 1/1/2011
  • Prognostic Relevance of Eight Genome Wide Association Studies-identified Single-nucleotide Polymorphisms in Primary Breast Cancer Bayraktar S, Thompson PA, Yoo SY, Do K, Sahin AA, Arun BK, Bondy ML, Brewster AM, AACR International Conference on Frontiers in Cancer Prevention Research, AACR Cancer Prevention Research, 1/1/2011
  • Prevalence of BRCA1 and BRCA2 Mutations in Women with Diagnosed with DCIS Elsayegh N, Bayraktar S, Gutierrez Barrera AM, Lin H, Kuerer HM, Muse KI, Ready K, Litton J, Meric-Bernstam F, Hortobagyi GN, Arun B, 47th ASCO Annual Meeting, J Clin Oncol, 1/1/2011

Lectures

  • Advances in the Management of BRCA-associated Breast Cancers Antalya, Turkey - 3/1/2012
  • Prognostic Relevance of Eight Genome Wide Association Studies-identified Single-nucleotide Polymorphisms in Primary Breast Cancer Boston, MA - 10/1/2011
  • Efficacy of Neoadjuvant Therapy with Trastuzumab Concurrent with Anthracycline- and Non-anthracycline-based Regimens for HER2-Positive Breast Cancer Chicago, IL - 6/1/2011

Other Languages

  • Turkish, Spanish

Hospital Affiliations

  • The full profile is locked and available to verified physicians only.
    Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

Physicians, view Dr. Bayraktar's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.GroupsHelpBlogCompanyContactPrivacyDirectory